ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

States Spent Only 3.2% Of Settlement Money On Smoking Cessation.

November 21, 2008

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998

Randomized Low-Fat Diet Trial To Being, Centers Sought

September 17, 1993